Cargando…

Resiquimod-Mediated Activation of Plasmacytoid Dendritic Cells Is Amplified in Multiple Sclerosis

Background: Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system. The cause of multiple sclerosis is unknown but there are several evidences that associate the genetic basis of the disease with environmental causes. An important association between viral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corsetti, Marta, Ruocco, Gabriella, Ruggieri, Serena, Gasperini, Claudio, Battistini, Luca, Volpe, Elisabetta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600519/ https://www.ncbi.nlm.nih.gov/pubmed/31181776 http://dx.doi.org/10.3390/ijms20112811

Ejemplares similares

Human Conventional and Plasmacytoid Dendritic Cells Differ in Their Ability to Respond to Saccharomyces cerevisiae
por: Sabatini, Andrea, et al.
Publicado: (2022)

Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis Patients
por: Capone, Alessia, et al.
Publicado: (2019)

CD28 Autonomous Signaling Up-Regulates C-Myc Expression and Promotes Glycolysis Enabling Inflammatory T Cell Responses in Multiple Sclerosis
por: Kunkl, Martina, et al.
Publicado: (2019)

Emerging oral treatments in multiple sclerosis – clinical utility of cladribine tablets
por: Gasperini, Claudio, et al.
Publicado: (2010)

Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, fingolimod will change therapeutic paradigm approach
por: Gasperini, Claudio, et al.
Publicado: (2012)

Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing–remitting multiple sclerosis
por: Ruggieri, Serena, et al.
Publicado: (2014)

Prognostic Accuracy of NEDA-3 in Long-term Outcomes of Multiple Sclerosis
por: Prosperini, Luca, et al.
Publicado: (2021)

FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients
por: Cencioni, M T, et al.
Publicado: (2015)

FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients
por: Cencioni, M T, et al.
Publicado: (2015)

Modulation of P2X7 Receptor during Inflammation in Multiple Sclerosis
por: Amadio, Susanna, et al.
Publicado: (2017)

Advances in the treatment of relapsing—remitting multiple sclerosis — critical appraisal of fingolimod
por: Gasperini, Claudio, et al.
Publicado: (2013)

FoxP3 isoforms and PD-1 expression by T regulatory cells in multiple sclerosis
por: Sambucci, Manolo, et al.
Publicado: (2018)

Determinants of COVID-19-related lethality in multiple sclerosis: a meta-regression of observational studies
por: Prosperini, Luca, et al.
Publicado: (2022)

Advances in T Helper 17 Cell Biology: Pathogenic Role and Potential Therapy in Multiple Sclerosis
por: Volpe, Elisabetta, et al.
Publicado: (2015)

Fas–Fas Ligand: Checkpoint of T Cell Functions in Multiple Sclerosis
por: Volpe, Elisabetta, et al.
Publicado: (2016)

Increased risk of death from COVID-19 in multiple sclerosis: a pooled analysis of observational studies
por: Prosperini, Luca, et al.
Publicado: (2021)

Increased risk of death from COVID-19 in multiple sclerosis: A meta-analysis of observational studies
por: Prosperini, Luca, et al.
Publicado: (2021)

A Squalene-Based Nanoemulsion for Therapeutic Delivery of Resiquimod
por: Zhang, Zhongkun, et al.
Publicado: (2021)

Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse
por: Longhini, Ana Leda F, et al.
Publicado: (2011)

The added value of spinal cord lesions to disability accrual in multiple sclerosis
por: Ruggieri, Serena, et al.
Publicado: (2023)

Plasmacytoid Dendritic Cells in Patients with MGUS and Multiple Myeloma
por: Knight, Andrea, et al.
Publicado: (2021)

Molecular Mechanisms Behind the Role of Plasmacytoid Dendritic Cells in Systemic Sclerosis
por: Silva, Inês S., et al.
Publicado: (2023)

Liposomal Resiquimod for Enhanced Immunotherapy of Peritoneal Metastases of Colorectal Cancer
por: Pauli, Griffin, et al.
Publicado: (2021)

Comparing the immunogenicity of glycosidase-directed resiquimod prodrugs mediated by cancer cell metabolism
por: Ryan, Austin T, et al.
Publicado: (2020)

Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis
por: Angelini, Daniela F., et al.
Publicado: (2013)

Plasmacytoid Dendritic Cells in Atherosclerosis
por: Döring, Yvonne, et al.
Publicado: (2012)

Plasmacytoid dendritic cells in dermatology()()
por: Dias de Oliveira, Natasha Favoretto, et al.
Publicado: (2021)

Plasmacytoid dendritic cell neoplasms
por: Lee, Yoo Jin, et al.
Publicado: (2023)

Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53
por: Rossi, Silvia, et al.
Publicado: (2014)

Effect of Natalizumab Treatment on Circulating Plasmacytoid Dendritic Cells: A Cross-Sectional Observational Study in Patients with Multiple Sclerosis
por: Kivisäkk, Pia, et al.
Publicado: (2014)

Blastic plasmacytoid dendritic cell neoplasm
por: Lencastre, André, et al.
Publicado: (2013)

Blastic plasmacytoid dendritic cell neoplasm
por: Rai, Manoj Ponadka, et al.
Publicado: (2018)

Disease-Associated Plasmacytoid Dendritic Cells
por: Li, Shuang, et al.
Publicado: (2017)

The Role of Plasmacytoid Dendritic Cells in Cancers
por: Zhou, Binhui, et al.
Publicado: (2021)

Plasmacytoid Dendritic Cells and Cancer Immunotherapy
por: Fu, Chunmei, et al.
Publicado: (2022)

Topically Applied Resiquimod versus Imiquimod as a Potential Adjuvant in Melanoma Treatment
por: Tambunlertchai, Supreeda, et al.
Publicado: (2022)

Dysregulated Homeostasis of Acetylcholine Levels in Immune Cells of RR-Multiple Sclerosis Patients
por: Di Bari, Maria, et al.
Publicado: (2016)

Interleukin-9 regulates macrophage activation in the progressive multiple sclerosis brain
por: Donninelli, Gloria, et al.
Publicado: (2020)

Plasmacytoid Dendritic Cells and the Control of Herpesvirus Infections
por: Baranek, Thomas, et al.
Publicado: (2009)

Blastic Plasmacytoid Dendritic Cell Neoplasm on the Scalp
por: Fukushi, Sawako, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_1b61hepob9rn457qgfga7nfm3h